Results showed 5F7GGC anti-HER2 Nb with [131I] IB-Mal-D-GEEEK had better tumor targeting than directly labeled Nb, indicating its potential for SPECT and PET imaging of HER2 + tumors [75]. The gene discussed is ERBB2; the disease is neoplasm.